{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:17:29Z","timestamp":1792844249710,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","aaojournal.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ophtha.2017.12.022","type":"journal-article","created":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T17:55:40Z","timestamp":1516384540000},"page":"904-912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential"],"prefix":"10.1016","volume":"125","author":[{"given":"Natasha M.","family":"van Poppelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda","family":"Vaarwater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardeep S.","family":"Mudhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Sisley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian G.","family":"Rennie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rundle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Brands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quincy C.C.","family":"van den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke W.","family":"Mensink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"de Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Kili\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Verdijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2017.12.022_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/09286580591000836","article-title":"Uveal and conjunctival malignant melanoma in Denmark, 1943-97: incidence and validation study","volume":"12","author":"Isager","year":"2005","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ophtha.2017.12.022_bib2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/bjo.73.8.591","article-title":"A\u00a0study of iris melanoma in Northern Ireland","volume":"73","author":"McGalliard","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.12.022_bib3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/eye.2011.272","article-title":"Differences in uveal melanomas between men and women from the British Isles","volume":"26","author":"Damato","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2017.12.022_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0420.2007.01011.x","article-title":"Incidence of iris melanoma in western Norway","volume":"86","author":"Krohn","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.12.022_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/09286580600553330","article-title":"Uveal and conjunctival malignant melanoma in Denmark 1943-97: observed and relative survival of patients followed through 2002","volume":"13","author":"Isager","year":"2006","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ophtha.2017.12.022_bib6","first-page":"10","article-title":"Iris melanoma: features and prognosis in 317 children and adults","volume":"16","author":"Shields","year":"2012","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.ophtha.2017.12.022_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/bjo.2010.181289","article-title":"Chromosomal aberrations in iris melanomas","volume":"95","author":"Mensink","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.12.022_bib8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/bjophthalmol-2013-303321","article-title":"Recurrence of iris melanoma after proton beam therapy","volume":"98","author":"Sandinha","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.12.022_bib9","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0161-6420(02)01104-1","article-title":"Diffuse iris melanoma: a report of 25 cases","volume":"109","author":"Demirci","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.12.022_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0161-6420(00)00449-8","article-title":"Iris melanoma: risk factors for metastasis in 169 consecutive patients","volume":"108","author":"Shields","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.12.022_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archophthalmol.2011.286","article-title":"Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study","volume":"130","author":"Khan","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.12.022_bib12","doi-asserted-by":"crossref","first-page":"213.e1","DOI":"10.1016\/j.ophtha.2012.08.016","article-title":"Gene expressing profiling of iris melanomas","volume":"120","author":"Harbour","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.12.022_bib13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/IAE.0b013e3181f57e62","article-title":"Cytogenetic testing of iris melanoma using fine needle aspiration biopsy in 17 patients","volume":"31","author":"Shields","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2017.12.022_bib14","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/bjophthalmol-2015-308301","article-title":"Genetic findings in treatment-naive and proton-beam-radiated iris melanomas","volume":"100","author":"Krishna","year":"2016","journal-title":"Br\u00a0J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.12.022_bib15","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","article-title":"Prognostic implications of monosomy 3 in uveal melanoma","volume":"347","author":"Prescher","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2017.12.022_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0165-4608(97)00230-6","article-title":"Cytogenetics of iris melanomas: disparity with other uveal tract melanomas","volume":"101","author":"Sisley","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.ophtha.2017.12.022_bib17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ophtha.2016.10.039","article-title":"Correlation of gene mutation status with copy number profile in uveal melanoma","volume":"124","author":"Yavuzyigitoglu","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.12.022_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/bjc.2013.299","article-title":"Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11","volume":"109","author":"Koopmans","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ophtha.2017.12.022_bib19","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.1167\/iovs.08-2145","article-title":"Oncogenic mutations in GNAQ occur early in uveal melanoma","volume":"49","author":"Onken","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2017.12.022_bib20","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/modpathol.2014.43","article-title":"Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma","volume":"27","author":"Koopmans","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ophtha.2017.12.022_bib21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/PAS.0000000000000645","article-title":"Comparing the prognostic value of BAP1 mutation pattern, chromosome 3 status, and BAP1 immunohistochemistry in uveal melanoma","volume":"40","author":"van de Nes","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ophtha.2017.12.022_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1088>3.0.CO;2-7","article-title":"Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization","volume":"30","author":"Naus","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ophtha.2017.12.022_bib23","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.1167\/iovs.13-12407","article-title":"Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance","volume":"54","author":"van den Bosch","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2017.12.022_bib24","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1001\/archopht.1981.03930020993002","article-title":"Are most iris \"melanomas' really nevi? A clinicopathologic study of 189 lesions","volume":"99","author":"Jakobiec","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.12.022_bib25","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1167\/iovs.17-21838","article-title":"Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma","volume":"58","author":"Scholz","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2017.12.022_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ng.3549","article-title":"Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma","volume":"48","author":"Moore","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.ophtha.2017.12.022_bib27","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.18632\/oncotarget.6614","article-title":"Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4","volume":"7","author":"Johansson","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ophtha.2017.12.022_bib28","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2017.12.022_bib29","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1167\/iovs.07-0440","article-title":"The T1799A BRAF mutation is present in iris melanoma","volume":"48","author":"Henriquez","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2017.12.022_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","article-title":"Improved survival with MEK inhibition in BRAF-mutated melanoma","volume":"367","author":"Flaherty","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2017.12.022_bib31","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1470-2045(12)70269-3","article-title":"Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial","volume":"13","author":"Falchook","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ophtha.2017.12.022_bib32","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/bjc.2013.804","article-title":"Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma","volume":"110","author":"Dono","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ophtha.2017.12.022_bib33","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ophtha.2016.01.023","article-title":"Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases","volume":"123","author":"Yavuzyigitoglu","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.12.022_bib34","doi-asserted-by":"crossref","first-page":"e0138002","DOI":"10.1371\/journal.pone.0138002","article-title":"Distribution of GNAQ and GNA11 mutation signatures in uveal melanoma points to a light dependent mutation mechanism","volume":"10","author":"de Lange","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ophtha.2017.12.022_bib35","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ajhg.2016.09.008","article-title":"Comprehensive genetic landscape of uveal melanoma by whole-genome sequencing","volume":"99","author":"Royer-Bertrand","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ophtha.2017.12.022_bib36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ophtha.2017.12.022_bib37","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1136\/bjophthalmol-2014-305047","article-title":"Prognostic parameters in uveal melanoma and their association with BAP1 expression","volume":"98","author":"van Essen","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.12.022_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/PAP.0b013e3181cfe758","article-title":"State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop","volume":"17","author":"Barnhill","year":"2010","journal-title":"Adv Anat Pathol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642017328440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642017328440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T13:21:35Z","timestamp":1535116895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642017328440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0161642017328440"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2017.12.022","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2017.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}